Open

Coming up

Don't miss

Replay


LATEST SHOWS

THE INTERVIEW

Dr Matshidiso Moeti, Former WHO Deputy Regional Director for Africa

Read more

MEDIAWATCH

Towards a 'Third Intifada'?

Read more

IN THE PAPERS

Germany and Russia discuss secret Ukraine deal

Read more

DEBATE

Iraq's Christians: Nowhere to Run? (part 2)

Read more

IN THE PAPERS

France commemorates a hero of the left

Read more

DEBATE

Iraq's Christians: Nowhere to Run?

Read more

WEB NEWS

Fake Twitter accounts spread chinese propaganda

Read more

FOCUS

What solutions for California's overcrowded prisons?

Read more

MIDDLE EAST MATTERS

Gaza conflict: Palestinians mark sombre Eid

Read more

  • Israel calls up 16,000 more reservist as Gaza death toll soars

    Read more

  • Scores feared dead in India landslide

    Read more

  • Video: Inside Hamas ‘terror’ tunnels in Gaza

    Read more

  • Sierra Leone quarantines Ebola outbreak epicentres

    Read more

  • Russia defiant as US, EU unveil 'phase three' sanctions

    Read more

  • Iraq's Christians: Nowhere to Run?

    Read more

  • US House votes to sue Obama for over-reaching his powers

    Read more

  • Argentina fails to reach deal with creditors

    Read more

  • Women should not laugh in public, Turkey's deputy PM says

    Read more

  • Suspect in Jewish Museum attack charged with 'terrorist' murder

    Read more

  • Fourth female suicide bomber targets Nigerian city

    Read more

  • US rebounds to 4% growth in second quarter

    Read more

  • Rats on the rampage at Louvre museum gardens

    Read more

  • 'Compelling' signs Kosovo leaders trafficked organs, prosecutor says

    Read more

Business

China probes France’s Sanofi for bribery

© AFP

Text by FRANCE 24

Latest update : 2013-08-11

French drugmaker Sanofi has been accused of dishing out almost $280,000 in bribes to Chinese doctors in 2007 in a bid to up its sales. Beijing corruption officials have opened a formal investigation.

French drugmaker Sanofi has been accused of dishing out almost $280,000 in bribes to Chinese doctors in 2007 in a bid to up its sales. Beijing corruption officials have opened a formal investigation, and Sanofi says it is taking the allegations very seriously.

The investigation, to be carried out by Beijing city health and corruption officials, was launched in response to claims by an unnamed whistleblower that the French company had paid 503 doctors a total of $274,000 to prescribe Sanofi products.

Sanofi said in a statement it was aware of the report but it said it was premature to comment on events that may have occurred in 2007.

However, it also stated that it took the allegations "very seriously", and as a company had zero tolerance for any unethical practices.

Payments to medical staff

The whilstleblower told the Guangzhou based, state owned, 21st Century Business Herald newspaper that in 2007 Sanofi paid doctors 80 yuan ($13) every time a patient bought its products, with the largest payment being 11,200 yuan.

Most of the payments were reportedly made to medical staff in hospitals in Beijing, the commercial hub of Shanghai, the southern city of Guangzhou and the eastern city of Hangzhou. The payments were disguised as grants for research programmes, the whilstleblower report claimed.

A spokesman told state news agency Xinhua that the Beijing municipal health bureau will coordinate with the disciplinary authorities to investigate the case.

The Sanofi allegations come after four executives from British drug firm GlaxoSmithKline (GSK) were arrested last month for alleged bribery and other offences. Chinese police detained the GSK executives on charges that they had funnelled up to 3 billion yuan ($489 million) to travel agencies to facilitate bribes to doctors and officials.

China's top economic planner is currently investigating 60 foreign and domestic pharmaceutical companies operating in China on similar grounds.

(FRANCE 24 with wires)

Date created : 2013-08-10

  • PHARMACEUTICAL INDUSTRY

    French giant Sanofi-Aventis bids 14.5 billion euros for US biotech firm Genzyme

    Read more

COMMENT(S)